美国 · SEC FORM 4
Mind Medicine (MindMed) Inc.
MNMD · Nasdaq · CIK 0001813814 · Healthcare
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
35 同一窗口内观察到的 Form 4 交易行
11 sales · 24 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 1 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2024-12-05 · GRYSKA DAVID W.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
FINRA 报告中没有该股票代码的空头余额。
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2024-12-05 | GRYSKA DAVID W | 买入 (P) | Common Shares | 2,500 | USD 7.17 | USD 17,925 | SEC 申报 ↗ |
| 2024-08-23 | GRYSKA DAVID W | 买入 (P) | Common Shares | 3,500 | USD 5.98 | USD 20,930 | SEC 申报 ↗ |
| 2024-08-20 | Barrow Robert | 买入 (P) | Common Shares | 500 | USD 6.12 | USD 3,060 | SEC 申报 ↗ |
| 2024-08-19 | Barrow Robert | 买入 (P) | Common Shares | 500 | USD 6.31 | USD 3,155 | SEC 申报 ↗ |
Form 4 申报证据
46 transaction lines in the latest 365-day window; 160 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-25 | Wiley Matthew T. | 卖出 (S) | Common Shares | 3,097 | USD 36.57 | USD 113,257 | SEC 申报 ↗ |
| 2026-09-25 | Sullivan Mark | 卖出 (S) | Common Shares | 14,051 | USD 36.57 | USD 513,845 | SEC 申报 ↗ |
| 2026-09-25 | Roberts Brandi | 卖出 (S) | Common Shares | 3,377 | USD 36.57 | USD 123,497 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-25 | Wiley Matthew T. | 卖出 (S) | Common Shares | 3,097 | USD 36.57 | USD 113,257 | SEC 申报 ↗ |
| 2026-09-25 | Sullivan Mark | 卖出 (S) | Common Shares | 14,051 | USD 36.57 | USD 513,845 | SEC 申报 ↗ |
| 2026-09-25 | Roberts Brandi | 卖出 (S) | Common Shares | 3,377 | USD 36.57 | USD 123,497 | SEC 申报 ↗ |
| 2026-09-25 | Karlin Daniel | 卖出 (S) | Common Shares | 10,853 | USD 36.57 | USD 396,894 | SEC 申报 ↗ |
| 2026-09-25 | Barrow Robert | 卖出 (S) | Common Shares | 31,550 | USD 36.57 | USD 1,153,784 | SEC 申报 ↗ |
| 2026-09-18 | Vallone Carol A | 期权行权／转换 (M) | Common Shares | 1,086 | USD 35.52 | USD 38,575 | SEC 申报 ↗ |
| 2026-09-18 | Krebs Andreas | 期权行权／转换 (M) | Common Shares | 1,629 | USD 35.52 | USD 57,862 | SEC 申报 ↗ |
| 2026-09-14 | Wiley Matthew T. | 奖励／授予 (A) | Common Shares | 125,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-14 | Sullivan Mark | 奖励／授予 (A) | Common Shares | 125,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-14 | Roberts Brandi | 奖励／授予 (A) | Common Shares | 125,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-14 | Karlin Daniel | 奖励／授予 (A) | Common Shares | 200,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-14 | Barrow Robert | 奖励／授予 (A) | Common Shares | 750,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-03 | Barrow Robert | 卖出 (S) | Common Shares | 19,023 | USD 37.94 | USD 721,733 | SEC 申报 ↗ |
| 2026-09-02 | Barrow Robert | 奖励／授予 (A) | Common Shares | 40,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-12 | Wiley Matthew T. | 奖励／授予 (A) | Common Shares | 62,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-12 | Sullivan Mark | 奖励／授予 (A) | Common Shares | 62,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-12 | Roberts Brandi | 奖励／授予 (A) | Common Shares | 62,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-12 | Karlin Daniel | 奖励／授予 (A) | Common Shares | 100,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-12 | Barrow Robert | 奖励／授予 (A) | Common Shares | 375,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-25 | Wiley Matthew T. | 卖出 (S) | Common Shares | 2,867 | USD 45.03 | USD 129,101 | SEC 申报 ↗ |
| 2026-06-25 | Sullivan Mark | 卖出 (S) | Common Shares | 13,008 | USD 45.03 | USD 585,750 | SEC 申报 ↗ |
| 2026-06-25 | Roberts Brandi | 卖出 (S) | Common Shares | 3,013 | USD 45.03 | USD 135,675 | SEC 申报 ↗ |
| 2026-06-25 | Karlin Daniel | 卖出 (S) | Common Shares | 10,035 | USD 45.03 | USD 451,876 | SEC 申报 ↗ |
| 2026-06-25 | Barrow Robert | 卖出 (S) | Common Shares | 29,208 | USD 45.03 | USD 1,315,236 | SEC 申报 ↗ |
| 2026-06-22 | Wiley Matthew T. | 奖励／授予 (A) | Common Shares | 62,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-22 | Sullivan Mark | 奖励／授予 (A) | Common Shares | 62,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-22 | Roberts Brandi | 奖励／授予 (A) | Common Shares | 62,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-22 | Karlin Daniel | 奖励／授予 (A) | Common Shares | 100,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-22 | Barrow Robert | 奖励／授予 (A) | Common Shares | 375,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-11 | Vallone Carol A | 奖励／授予 (A) | Common Shares | 4,666 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | MNMD |
| CIK | 0001813814 |
| 行业 | Healthcare |
| 细分行业 | — Yahoo Finance |
| SEC SIC | 2833 Medicinal Chemicals & Botanical Products |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 160 transaction lines from 2022-01-15 to 2026-09-25 4 P purchase lines · 82 S sale lines · 74 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.